The novel molecule of AJs, AJAP1, was found to be a tumor suppressor in glioma, hepatocellular carcinoma, esophagus carcinoma, oligodendrogliomas, and cervical cancer [12–14, 17, 43–45]. This evidence concerns the gene AJAP1 and central nervous system cancer.